How we build (and keep building) Enso

Nov 18, 2026

How we build (and keep building) Enso

Enso is Hinge Health’s FDA-cleared device for pain relief backed by approximately 40 patents and pending patent applications. Members apply Enso's gel pads to the site of pain, and the device delivers gentle electrical pulses through the skin to help interrupt pain signals and stimulate the body's natural pain relief response – all controlled through the Hinge Health app.

78% of Enso users report pain relief within the first 3+ months of use, and of those who responded to the post-session pain check, 93% reported improvement.¹ Backed by this clinical evidence and strong member engagement, Enso is a beloved part of the Hinge Health care model thanks to close collaboration between expert clinical guidance, intentional product design, and rigorous testing before Enso ever reaches a member. 

Today, as we expand into new areas of care like migraine, we’re pulling back the curtain on how Enso comes to life from a clinical hypothesis to a working device in members’ hands.

Bringing a new Enso use case to life 

Step 1: Proving the clinical case

The value of Enso is the clinical discipline behind each use case, from musculoskeletal (MSK) pain to migraine pain and beyond. Every new area of care starts with an assessment of the potential target condition to find out whether transcutaneous electrical nerve stimulation (TENS) technology is already used to treat it, and where Hinge Health can add value. Our clinicians evaluate when and for whom this treatment is effective, where it fits into a broader treatment plan, and what safety guardrails need to be in place. 

That clinical groundwork shapes the treatment parameters themselves, including which nerves to target, gel pad geometry, and waveform characteristics like pulse width, frequency, and amplitude range. We test these parameters in stages before translating what we learn into a clinically sound, usable experience.

Step 2: Defining the parameters and developing the hardware  

Clinical and market research become product requirements for our Hardware team to iterate on for electrical, mechanical, and firmware designs. In parallel, our Product team prototypes the member experience to understand how they will use the treatment in real life, and how the experience should fit alongside a member’s exercise therapy and care team support. 

We test and refine treatment using these prototypes before finalizing the design and testing its efficacy. For example, during the development phase of our Migraine Care Program, our internal study indicated that Enso was 2.4x more likely to reduce pain vs. placebo, reaffirming that our assessment of the problem and our proprietary solution were aligned to relieve pain for the right population.² 

Step 3: Developing the final product

The final phase brings the systems together. We finalize hardware components, build the production app experience, and coordinate with the Care Team, Support, and others to make sure the newest iteration works for members and our clinicians. 

Most importantly, before anything ships, we verify and validate that the integrated device meets its approved requirements. Only then do we ramp up manufacturing, assembly processes and quality controls to scale to full production.

What's Next

Enso is an evolving technology built around a simple goal: help more people access meaningful pain relief to keep moving. As we learn more from members, PTs, and new clinical research, Enso becomes more precise, more usable, and more relevant for additional needs. 

This is how a clinical idea becomes a product designed around the needs of members and clinicians, and how Enso will continue to evolve. As we continue expanding into new areas of care, our process remains grounded in clinical rigor and built for real member outcomes. 

This article is provided for informational purposes only and does not constitute medical advice specific to you or your medical condition. Please consult your healthcare provider with any questions about your medical condition or treatment. Enso for Migraine is indicated for adults 18 and older who have been diagnosed with migraine by a physician, for acute treatment of migraine with or without aura and for preventative treatment of migraine.
  1. Hinge Health (2026). Internal analysis of in-app post-session pain ratings from 254,036 members who completed their first 20+ minute Enso session between May 2025 and May 2026, using each member's ratings from their first 90 days of use.
  2. Hinge Health (2025) Internal unpublished study using Enso to apply TENS stimulation for migraine pain.